Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study

BACKGROUND: Transarterial chemoembolization (TACE) and sorafenib are the therapeutic standard for intermediate and advanced stage hepatocellular carcinoma (HCC) patients respectively. High costs with adverse events (AE) of sorafenib might limit sorafenib dosage, further affecting therapeutic respons...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Gastroenterol
Huvudupphovsmän: Hsiao, Wang-De, Peng, Cheng-Yuan, Chuang, Po-Heng, Lai, Hsueh-Chou, Cheng, Ken-Sheng, Chou, Jen-Wei, Chen, Yang-Yuan, Yu, Cheng-Ju, Feng, Chun-Lung, Su, Wen-Pang, Chen, Sheng-Hung, Kao, Jung-Ta
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847248/
https://ncbi.nlm.nih.gov/pubmed/27117280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-016-0464-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk